Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines

Sanaria Inc. has developed methods to manufacture, purify and cryopreserve aseptic Plasmodium falciparum (Pf) sporozoites (SPZ), and is using this platform technology to develop an injectable PfSPZ-based vaccine that provides high-grade, durable protection against infection with Pf malaria. Several...

Descripción completa

Detalles Bibliográficos
Autores principales: Richie, Thomas L., Billingsley, Peter F., Sim, B. Kim Lee, James, Eric R., Chakravarty, Sumana, Epstein, Judith E., Lyke, Kirsten E., Mordmüller, Benjamin, Alonso, Pedro, Duffy, Patrick E., Doumbo, Ogobara K., Sauerwein, Robert W., Tanner, Marcel, Abdulla, Salim, Kremsner, Peter G., Seder, Robert A., Hoffman, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077156/
https://www.ncbi.nlm.nih.gov/pubmed/26469720
http://dx.doi.org/10.1016/j.vaccine.2015.09.096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077156/
https://www.ncbi.nlm.nih.gov/pubmed/26469720
http://dx.doi.org/10.1016/j.vaccine.2015.09.096

Ejemplares similares